- Report
- November 2023
- 30 Pages
Global
From €2853EUR$3,250USD£2,467GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2414EUR$2,750USD£2,088GBP
- Report
- April 2025
- 183 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- September 2024
- 82 Pages
Japan
From €3072EUR$3,500USD£2,657GBP
- Report
- September 2024
- 82 Pages
Japan
From €3072EUR$3,500USD£2,657GBP
- Report
- August 2024
- 80 Pages
Japan
From €3072EUR$3,500USD£2,657GBP
- Report
- October 2023
- 190 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- June 2023
- 112 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1317EUR$1,500USD£1,139GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1755EUR$2,000USD£1,518GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,139GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €6978EUR$7,950USD£6,035GBP
- Report
- April 2023
- 137 Pages
Global
From €6583EUR$7,500USD£5,693GBP
- Report
- February 2022
- 210 Pages
Global
From €6583EUR$7,500USD£5,693GBP
- Report
- July 2024
- 200 Pages
Global
From €4344EUR$4,949USD£3,757GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more